Αποτελέσματα αναζήτησης - "высокодифференцированный рак щитовидной железы"

1

Academic Journal

Place of istmusectomy in thyroid tumors management: experience of National Medical Research Center of Endocrinology ; Истмусэктомия в лечении опухолевых образований щитовидной железы: опыт Национального медицинского исследовательского центра эндокринологии

Συγγραφείς: P. A. Nikiforovich, D. G. Beltsevich, M. S. Berlovich, П. А. Никифорович, Д. Г. Бельцевич, М. С. Берлович

Πηγή: Head and Neck Tumors (HNT); Том 15, № 1 (2025); 20-25 ; Опухоли головы и шеи; Том 15, № 1 (2025); 20-25 ; 2411-4634 ; 2222-1468

Θεματικοί όροι: высокодифференцированный рак щитовидной железы, removal of the thyroid isthmus, thyroid tumor, well-differentiated thyroid cancer, удаление перешейка щитовидной железы, опухоль щитовидной железы

Περιγραφή αρχείου: application/pdf

Relation: https://ogsh.abvpress.ru/jour/article/view/1038/656; Houten P.V., Netea-Maier R.T., Smit J.W. Differentiated thyroid carcinoma: An update. Best Pract Res Clin Endocrinol Metab 2023;37(1):101687. DOI:10.1016/j.beem.2022.101687; Maleki Z., Hassanzadeh J., Ghaem H. Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study. BMC Cancer 2024;24(1):467. DOI:10.1186/s12885-024-12176-y; Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. 252 с.; Boucai L., Zafereo M., Cabanillas M.E. Thyroid cancer: a review. JAMA 2024;31(5):425–35. DOI:10.1001/jama.2023.26348; Чойнзонов Е.Л., Решетов И.В., Иванов С.А. и др. Проект клинических рекомендаций по диагностике и лечению дифференцированного рака щитовидной железы у взрослых пациентов. Эндокринная хирургия 2022;16(2):5–29. DOI:10.14341/serg12792; Usman M., Yao P., Luckett K. et al. The use of thyroid isthmusectomy for management of well differentiated thyroid carcinoma – a systematic review and meta-analysis. Surg Oncol 2024;52:102032. DOI:10.1016/j.suronc.2023.102032; Shaha A.R., Nigam A., Tuttle R.M. Commentary: wide-field isthmusectomy for localized isthmic thyroid tumors. Surg Oncol 2025;58:102185. DOI:10.1016/j.suronc.2024.102185; Dai Y., Feng Q. Papillary thyroid carcinoma of isthmus: total thyroidectomy or isthmusectomy? Gland Surg 2024;13(3):465–6. DOI:10.21037/gs-23-502; Hahn S.Y., Han B.K. et al. Ultrasound findings of papillary thyroid carcinoma originating in the isthmus: comparison with lobeoriginating papillary thyroid carcinoma. AJR Am J Roentgenol 2014;203(3):637–42. DOI:10.2214/AJR.13.10746; Luo H., Yan F., Lan L. et al. Ultrasonographic features, nodule size, capsular invasion, and lymph node metastasis of solitary papillary carcinoma of thyroid isthmus. Front Oncol 2020;10:558363. DOI:10.3389/fonc.2020.558363; Lee Y.C., Na S.Y., Chung H. et al. Clinicopathologic characteristics and pattern of central lymph node metastasis in papillary thyroid cancer located in the isthmus. Laryngoscope 2016;126(10):2419–21. DOI:10.1002/lary.25926; Li G., Lei J., Peng Q. et al. Lymph node metastasis characteristics of papillary thyroid carcinoma located in the isthmus: a singlecenter analysis. Medicine (Baltimore) 2017;96(24):e7143. DOI:10.1097/MD.0000000000007143; Goldfarb M., Rodgers S.S., Lew J.I. Appropriate surgical procedure for dominant thyroid nodules of the isthmus 1 cm or larger. Arch Surg 2012;147(9):881–4. DOI:10.1001/archsurg.2012.728; Zhou L., Gao C., Li H. et al. Isthmic papillary thyroid carcinoma presents a unique pattern of central lymph node metastasis. Cancer Manag Res 2020;12:3643–50. DOI:10.2147/CMAR.S252692; Vasileiadis I., Boutzios G., Karalaki M. et al. Papillary thyroid carcinoma of the isthmus: total thyroidectomy or isthmusectomy? Am J Surg 2018;216(1):135–9. DOI:10.1016/j.amjsurg.2017.09.008; Olmos Borzone R.I., López Ruiz-Esquide J.A., Domínguez Covarrubias F. et al. Isthmusectomy for well-differentiated thyroid carcinoma located to the isthmus: a report of two cases and review of the literature. Medwave 2021;21(10):e8493. DOI:10.5867/medwave.2021.10.8493; Kwon O., Lee S., Bae J.S. et al. Thyroid isthmusectomy with prophylactic central compartment neck dissection is a feasible approach for papillary thyroid cancer on the isthmus. Ann Surg Oncol 2021;28(11):6603–12. DOI:10.1245/s10434-021-09833-y; https://ogsh.abvpress.ru/jour/article/view/1038

Διαθεσιμότητα: https://ogsh.abvpress.ru/jour/article/view/1038
https://doi.org/10.17650/2222-1468-2025-15-1-20-25

View record from BASE

2

Academic Journal

Preventive central neck lymph node dissection as a stage in the treatment of papillary thyroid cancer ; Профилактическая центральная шейная лимфодиссекция как этап в лечении папиллярного рака щитовидной железы

Συγγραφείς: М. S. Tigrov, L. P. Yakovleva, М. А. Kropotov, S. S. Menshikova, М. С. Тигров, Л. П. Яковлева, М. А. Кропотов, С. С. Меньшикова

Πηγή: Malignant tumours; Том 14, № 1 (2024); 39-46 ; Злокачественные опухоли; Том 14, № 1 (2024); 39-46 ; 2587-6813 ; 2224-5057

Θεματικοί όροι: щитовидная железа, тиреоидэктомия, лимфодиссекция, папиллярный рак, высокодифференцированный рак щитовидной железы, гипопаратиреоз, возвратный гортанный нерв, thyroidectomy, lymph node dissection, papillary cancer, highly differentiated thyroid cancer, hypoparathyroidism, recurrent laryngeal nerve

Περιγραφή αρχείου: application/pdf

Relation: https://www.malignanttumors.org/jour/article/view/1292/926; Seib C.D., Sosa J.A. Evolving Understanding of the Epidemiology of Thyroid Cancer. Endocrinol Metab Clin North Am 2019;48(1):23–35. https://doi.org/10.1016/j.ecl.2018.10.002; Filetti S., Durante C., Hartl D., et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol 2019;30(12):1856–1883. https://doi.org/10.1093/annonc/mdz400; Wrenn S.M., Wang T.S., Toumi A., et al. Practice patterns for surgical management of low-risk papillary thyroid cancer from 2014 to 2019: A CESQIP analysis. Am J Surg 2021;221(2):448–454. https://doi.org/10.1016/j.amjsurg.2020.07.032; Giuffrida D., Giuffrida R., Puliafito I., et al. Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer. Int J Surg Oncol 2019;2019:2715260. https://doi.org/10.1155/2019/2715260; Pacini F., Elisei R., Capezzone M., et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 2001;11(9):877–81. https://doi.org/10.1089/105072501316973145; Клинические рекомендации. Дифференцированный рак щитовидной железы, 2020. Доступно по: https://cr.minzdrav.gov.ru/recomend/329_1.; Haymart M.R., Banerjee M., Reyes-Gastelum D., et al. Thyroid Ultrasound and the Increase in Diagnosis of Low-Risk Thyroid Cancer. J Clin Endocrinol Metab 2019;104(3):785–792. https://doi.org/10.1210/jc.2018-01933; Azizi G., Faust K., Ogden L., et al. 3-D Ultrasound and Thyroid Cancer Diagnosis: A Prospective Study. Ultrasound Med Biol 2021;47(5):1299–1309. https://doi.org/10.1016/j.ultrasmedbio.2021.01.010; Kim S.K., Woo J.W., Park I., et al. Computed Tomography-Detected Central Lymph Node Metastasis in Ultrasonography Node-Negative Papillary Thyroid Carcinoma: Is It Really Significant? Ann Surg Oncol 2017;24(2):442–449. https://doi.org/10.1245/s10434-016-5552-1; Zhao H., Li H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: Diagnosis of central and lateral compartment nodal metastases. Eur J Radiol 2019;112:14–21. https://doi.org/10.1016/j.ejrad.2019.01.006; van Velsen E.F. S., Stegenga M.T., van Kemenade F.J., et al. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients. Thyroid 2019;29(8):1073–1079. https://doi.org/10.1089/thy.2019.0053; Roh J.-L., Kim J.-M., Park C.I. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann Surg Oncol 2011;18(8):2245–50. https://doi.org/10.1245/s10434-011-1600-z; Wu Y., Gu J., Shang J., et al. Central lymph node metastasis in cN0 papillary thyroid carcinoma. J BUON 2013;18(3):733–8. PMID: 24065492; Koo B.S., Choi E.C., Yoon Y.-H., et al. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg 2009;249(5):840–4. https://doi.org/10.1097/SLA.0b013e3181a40919; Li Z., Qu X.-C., Cheng B. The characteristics of papillary thyroid cancer lymph node metastasis and the clinical significance of central region cervical lymph node dissection. Zhonghua Wai Ke Za Zhi 2008;46(18):1407–9. PMID: 19094514; Sadowski B.M., Snyder S.K., Lairmore T.C. Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery 2009;146(4):696–703. https://doi.org/10.1016/j.surg.2009.06.046; Dobrinja C., Troian M., Cipolat Mis T., et al. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center. Int J Surg 2017;41 Suppl 1: S40-S47. https://doi.org/10.1016/j.ijsu.2017.01.113; Kim S.K., Woo J.-W., Lee J.H., et al. Prophylactic Central Neck Dissection Might Not Be Necessary in Papillary Thyroid Carcinoma: Analysis of 11,569 Cases from a Single Institution. J Am Coll Surg 2016;222(5):853–64. https://doi.org/10.1016/j.jamcollsurg.2016.02.001; Alvarado R., Sywak M.S., Delbridge L., Sidhu S.B. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity? Surgery 2009;145(5):514–8. https://doi.org/10.1016/j.surg.2009.01.013; Shen W.T., Ogawa L., Ruan D., et al. Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperation. Arch Surg 2010;145(3):272–275. https://doi.org/10.1001/archsurg.2010.9; Hall C.M., LaSeur D.C., Snyder S.K., Lairmore T. Reoperative central lymph node dissection for incidental papillary thyroid cancer can be performed safely: A retrospective review. Int J Surg 2018;56:102–107. https://doi.org/10.1016/j.ijsu.2018.06.015; Nylén C., Eriksson F.B., Yang A., et al. Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer. Am J Surg 2021;221(5):886–892. https://doi.org/10.1016/j.amjsurg.2020.08.012; Shuchleib-Cung A., Garcia-Gordillo J.A., Ferreira-Hermosillo A., Mercado M. Risk factors for hypocalcemia after total thyroidectomy. Cir Cir 2022;90(6):765–769. https://doi.org/10.24875/CIRU.21000579; White M.L., Doherty G.M. Level VI lymph node dissection for papillary thyroid cancer. Minerva Chir 2007;62(5):383–93. PMID: 17947949; Spartalis E., Ntokos G., Georgiou K., et al. Intraoperative Indocyanine Green (ICG) Angiography for the Identification of the Parathyroid Glands: Current Evidence and Future Perspectives. In Vivo 2020;34(1):23–32. https://doi.org/10.21873/invivo.11741; Priyanka S., Sam S.T., Rebekah G., et al. The utility of indocyanine green (ICG) for the identification and assessment of viability of the parathyroid glands during thyroidectomy. Updates Surg 2022;74(1):97–105. https://doi.org/10.1007/s13304-021-01202-4; Макарьин В.А., Успенская А.А., Алексеев М.А. и соавт. Интраоперационный нейромониторинг при оперативных вмешательствах на щитовидной и околощитовидных железах: показания к проведению, методика выполнения. Эндокринная хирургия. 2016;10(2):5–17. https://doi.org/10.14341/serg201625-17; De Crea C., Raffaelli M., Sessa L., et al. Surgical approach to level VI in papillary thyroid carcinoma: an overview. Updates Surg 2017;69(2):205–209. https://doi.org/10.1007/s13304-017-0468-2.; https://www.malignanttumors.org/jour/article/view/1292

Διαθεσιμότητα: https://www.malignanttumors.org/jour/article/view/1292
https://doi.org/10.18027/2224-5057-2024-14-1-39-46

View record from BASE

3

Academic Journal

The role of the study of the level of thyroglobulin in the washout fuid of the needle aspiration for the detection of cervical lymph node metastases in well-differentiated thyroid cancer ; Роль исследования уровня тиреоглобулина в смыве из пункционной иглы в диагностике метастазов в лимфатических узлах шеи при высокодифференцированном раке щитовидной железы

Συγγραφείς: E. Kh. Gogieva, I. S. Romanov, E. E. Stanyakina, S. N. Berdnikov, E. L. Pimenova, A. I. Umarova, Э. Х. Гогиева, И. С. Романов, Е. Е. Станякина, С. Н. Бердников, Е. Л. Пименова, А. И. Умарова

Πηγή: Siberian journal of oncology; Том 22, № 2 (2023); 5-13 ; Сибирский онкологический журнал; Том 22, № 2 (2023); 5-13 ; 2312-3168 ; 1814-4861

Θεματικοί όροι: высокодифференцированный рак щитовидной железы, fine-needle aspiration biopsy, highly differentiated thyroid cancer, тонкоигольная аспирационная биопсия

Περιγραφή αρχείου: application/pdf

Relation: https://www.siboncoj.ru/jour/article/view/2523/1090; Sherman S.I. Thyroid carcinoma. Lancet. 2003; 361(9356): 501–11. doi:10.1016/s0140-6736(03)12488-9.; Злокачественные новообразования в России в 2020 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М., 2021. 252 с.; Eun N.L., Son E.J., Kim J.A., Gweon H.M., Kang J.H., Youk J.H. Comparison of the diagnostic performances of ultrasonography, CT and fine needle aspiration cytology for the prediction of lymph node metastasis in patients with lymph node dissection of papillary thyroid carcinoma: A retrospective cohort study. Int J Surg. 2018; 51: 145–50. doi:10.1016/j.ijsu.2017.12.036.; Mazzaferri E.L., Kloos R.T. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001; 86(4): 1447–63. doi:10.1210/jcem.86.4.7407.; Khadra H., Mohamed H., Al-Qurayshi Z., Sholl A., Killackey M., Kandil E. Superior detection of metastatic cystic lymphadenopathy in patients with papillary thyroid cancer by utilization of thyroglobulin washout. Head Neck. 2019; 41(1): 225–9. doi:10.1002/hed.25488.; Liu R.B., Zhou D.L., Xu B.H., Yang X.H., Liu Q., Zhang X., Tang T., Ye Z.L., Li Y. Comparison of the diagnostic performances of US-guided fine needle aspiration cytology and thyroglobulin measurement for lymph node metastases in patients with diferentiated thyroid carcinoma: a meta-analysis. Eur Radiol. 2021; 31(5): 2903–14. doi:10.1007/s00330-020-07400-9.; Ton Eryilmaz O., Ucak R., Ozagari A.A., Kabukcuoglu F. Diagnostic value of lymph node fine-needle aspiration cytology. Cytojournal. 2021; 18: 8. doi:10.25259/Cytojournal_1_2020.; Pacini F., Fugazzola L., Lippi F., Ceccarelli C., Centoni R., Miccoli P., Elisei R., Pinchera A. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic diferentiated thyroid cancer. J Clin Endocrinol Metab. 1992; 74(6): 1401–4. doi:10.1210/jcem.74.6.1592886.; Bakuła-Zalewska E., Żyłka A., Długosińska J., Musiał E., Gałczyński J., Dedecjus M. Thyroglobulin measurements in washouts of fine-needle aspiration biopsy in the monitoring of patients with diferentiated thyroid carcinoma. Endokrynol Pol. 2021; 72(6): 601–8. doi:10.5603/EP.a2021.0077.; Li J., Zhang K., Liu X., Hao F., Liu Z., Wang Z. Cervical lymph node thyroglobulin measurement in washout of fine-needle aspirates for diagnosis of papillary thyroid cancer metastases. Br J Biomed Sci. 2016; 73(2): 79–83. doi:10.1080/09674845.2016.1173334.; Zhu X.H., Zhou J.N., Qian Y.Y., Yang K., Wen Q.L., Zhang Q.H., Xia L., Ge M.H., Sun C.X. Diagnostic values of thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis diagnostic values of FNA-Tg. Endocr J. 2020; 67(2): 113–23. doi:10.1507/endocrj.EJ18-0558.; Jun H.H., Kim S.M., Kim B.W., Lee Y.S., Chang H.S., Park C.S. Overcoming the limitations of fine needle aspiration biopsy: detection of lateral neck node metastasis in papillary thyroid carcinoma. Yonsei Med J. 2015; 56(1): 182–8. doi:10.3349/ymj.2015.56.1.182.; Yu J., Song Y., Jiang Z. Usefulness of thyroglobulin in cervical lymph node fine-needle aspirations at initial thyroidectomy for the diagnosis of metastases in papillary thyroid cancer. Int J Clin Pharmacol Ther. 2017; 55(1): 85–8. doi:10.5414/CP202642.; Xiao J., Meng S., Zhang M., Li Y., Yan L., Li X., Yang Z., Zhang Y., Luo Y. Optimal method for detecting cervical lymph node metastasis from papillary thyroid cancer. Endocrine. 2023; 79(2): 342–8. doi:10.1007/s12020-022-03213-6.; Cignarelli M., Ambrosi A., Marino A., Lamacchia O., Campo M., Picca G., Giorgino F. Diagnostic utility of thyroglobulin detection in fine-needle aspiration of cervical cystic metastatic lymph nodes from papillary thyroid cancer with negative cytology. Thyroid. 2003; 13(12): 1163–7. doi:10.1089/10507250360731578.; Al-Hilli Z., Strajina V., McKenzie T.J., Thompson G.B., Farley D.R., Regina Castro M., Algeciras-Schimnich A., Richards M.L. Thyroglobulin Measurement in Fine-Needle Aspiration Improves the Diagnosis of Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma. Ann Surg Oncol. 2017; 24(3): 739–44. doi:10.1245/s10434-016-5625-1.; Haugen B.R., Alexander E.K., Bible K.C., Doherty G.M., Mandel S.J., Nikiforov Y.E., Pacini F., Randolph G.W., Sawka A.M., Schlumberger M., Schuff K.G., Sherman S.I., Sosa J.A., Steward D.L., Tuttle R.M., Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Diferentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Diferentiated Thyroid Cancer. Thyroid. 2016; 26(1): 1–133. doi:10.1089/thy.2015.0020.; Li F., Pan D., He Y., Wu Y., Peng J., Li J., Wang Y., Yang H., Chen J. Using ultrasound features and radiomics analysis to predict lymph node metastasis in patients with thyroid cancer. BMC Surg. 2020; 20(1): 315. doi:10.1186/s12893-020-00974-7.; Xing Z., Qiu Y., Yang Q., Yu Y., Liu J., Fei Y., Su A., Zhu J. Thyroid cancer neck lymph nodes metastasis: Meta-analysis of US and CT diagnosis. Eur J Radiol. 2020; 129. doi:10.1016/j.ejrad.2020.109103.; Melany M., Chen S. Thyroid Cancer: Ultrasound Imaging and Fine-Needle Aspiration Biopsy. Endocrinol Metab Clin North Am. 2017; 46(3): 691–711. doi:10.1016/j.ecl.2017.04.011.; Kahramangil B., Kose E., Donmez M., Aydin H., Reynolds J.P., Krishnamurthy V., Jin J., Shin J., Siperstein A., Berber E. Thyroglobulin washout from cervical lymph node fine-needle aspiration biopsies in patients with diferentiated thyroid cancer: an analysis of diferent expressions to use in post-total thyroidectomy follow-up. Surgery. 2020; 167(1): 34–9. doi:10.1016/j.surg.2019.05.083.; Martins-Costa M.C., Maciel R.M.B., Kasamatsu T.S., Nakabashi C.C.D., Camacho C.P., Crispim F., Ikejiri E.S., Mamone M.C.O., Andreoni D.M., Biscolla R.P.M. Clinical impact of thyroglobulin (Tg) and Tg autoantibody (TgAb) measurements in needle washouts of neck lymph node biopsies in the management of patients with papillary thyroid carcinoma. Arch Endocrinol Metab. 2017; 61(2): 108–14. doi:10.1590/2359-3997000000241.; da Silveira Duval M.A., Zanella A.B., Cristo A.P., Faccin C.S., Graudenz M.S., Maia A.L. Impact of Serum TSH and Anti-Thyroglobulin Antibody Levels on Lymph Node Fine-Needle Aspiration Thyroglobulin Measurements in Diferentiated Thyroid Cancer Patients. Eur Thyroid J. 2017; 6(6): 292–7. doi:10.1159/000479682.; https://www.siboncoj.ru/jour/article/view/2523

Διαθεσιμότητα: https://www.siboncoj.ru/jour/article/view/2523
https://doi.org/10.21294/1814-4861-2023-22-2-5-13

View record from BASE

4

Academic Journal

The effectiveness of the method for determining the level of thyroglobulin in needle washouts of fine-needle aspiration biopsy in the differential diagnosis of metastases of highly differentiated thyroid cancer in the lymph nodes of the neck ; Эффективность метода определения уровня тиреоглобулина в смыве из пункционной иглы в дифференциальной диагностике метастазов высокодифференцированного рака щитовидной железы в лимфатических узлах шеи

Συγγραφείς: E. E. Stanyakina, I. S. Romanov, E. Kh. Gogieva, A. V. Ignatova, Yu. V. Alymov, K. D. Ilkaev, Е. Е. Станякина, И. С. Романов, Э. Х. Гогиева, А. В. Игнатова, Ю. В. Алымов, К. Д. Илькаев

Πηγή: Head and Neck Tumors (HNT); Том 12, № 3 (2022); 10-16 ; Опухоли головы и шеи; Том 12, № 3 (2022); 10-16 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2022-12-3

Θεματικοί όροι: высокодифференцированный рак щитовидной железы, fine-needle aspiration biopsy, cervical lymphadenopathy, highly differentiated thyroid cancer, тонкоигольная аспирационная биопсия, лимфаденопатия шеи

Περιγραφή αρχείου: application/pdf

Relation: https://ogsh.abvpress.ru/jour/article/view/810/538; Dal Maso L., Tavilla A., Pacini F. et al. Survival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5. Eur J Cancer 2017;77:140–52. DOI:10.1016/j.ejca.2017.02.023; Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2017. C. 33, 151.; Haugen B.R., Alexander E.K., Bible K.C. et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26(1):1–133. DOI:10.1089/thy.2015.0020; Зураева З.Т., Никанкина Л.В., Колесникова Г.С. и др. Определение тиреоглобулина в смыве из пункционной иглы в дифференциальной диагностике шейной лимфаденопатии у пациентов с высокодифференцированным раком щитовидной железы. Эндокринная хирургия 2019;13(1):17–25. DOI: https://doi.org/10.14341/serg9824; Бельцевич Д.Г., Ванушко В.Э., Румянцев П.О. и др. Россий кие клинические рекомендации по диагностике и лечению высокодифференцированного рака щитовидной железы у взрослых. Эндокринная хирургия 2017;11(1):6–27. DOI:10.14341/serg20171627; Chai Y.J., Suh H., Yi J.W. et al. Factors associated with the sensitivity of fineneedle aspiration cytology for the diagnosis of follicular variant papillary thyroid carcinoma. Head Neck 2016;38(1):E1467–71. DOI: https://doi.org/10.1002/hed.24261; Johnson N.A., Tublin M.E. Postoperative surveillance of differentiated thyroid carcinoma: rationale, techniques, and controversies. Radiolog 2008;249(2):429–44. DOI:10.1148/radiol.2492071313; Pacini F., Fugazzola L., Lippi F. et al. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer. J Clin Endocrinol Metab 1992;74(6):1401–4. DOI:10.1210/jcem.74.6.1592886; Cooper S.D., Doherty G.M., Haugen B.R. et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19(11):1167–214. DOI:10.1089/thy.2009.0110; Stack B.C., Ferris R.L., Goldenberg D. et al. American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 2012;22(5):501–8. DOI:10.1089/thy.2011.0312; Leenhardt L., Erdogan M.F., Hegedus L. et al. 2013 European Thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyroid J 2013;2(3):147–59. DOI:10.1159/000354537; Torres M., Neto S., Rosas R. et al. Thyroglobulin in the washout fluid of lymph-node biopsy: What is its role in the follow-up of differentiated thyroid carcinoma? Thyroid 2014;24(1):7–18. DOI:10.1089/thy.2013.0244; Baskin H.J. Detection of recurrent papillary thyroid carcinoma by thyroglobulin assessment in the needle washout by fine-needle aspiration of suspicious lymph nodes. Thyroid 2004;14(11):959–63. DOI:10.1089/thy.2004.14.959; Cignarelli M., Ambrosi A., Marino A. et al. Diagnostic utility of thyroglobulin detection in fine-needle aspiration of cervical cystic metastatic lymph nodes from papillary thyroid cancer with negative cytology. Thyroid 2003;13(12):1163–7. DOI:10.1089/10507250360731578; Uruno T., Miyauchi A., Shimizu K. et al. Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg 2005;29(4):483–5. DOI:10.1007/s00268-004-7701-0; Jeon S.J., Kim E., Park J.S. et al. Diagnostic benefit of thyroglobulin measurement in fine-needle aspiration for diagnosing metastatic cervical lymph nodes from papillary thyroid cancer: correlations with US features. Korean J Radiol 2009;10(2):106–11. DOI:10.3348/kjr.2009.10.2.106; Sigstad E., Heilo A., Paus E. et al. The usefulness of detecting thyroglobulin in fine-needle aspirates from patients with neck lesions using a sensitive thyroglobulin assay. Diagn Cytopathol 2007;35(12):761–7. DOI:10.1002/dc.20726; Kim D.W., Jeon S.J., Kim C.G. Usefulness of thyroglobulin measurement in needle washouts of fine-needle aspiration biopsy for the diagnosis of cervical lymph node metastases from papillary thyroid cancer before thyroidectomy. Endocrine 2012;42(2):399–403. DOI:10.1007/s12020-012-9636-9; Boi F., Baghino G., Atzeni F. et al. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies. J Clin Endocrinol Metab 2006;91(4):1364–9. DOI:10.1210/jc.2005-1705; Grani G., Fumarola A. Thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis of diagnostic accuracy J Clin Endocrinol Metab 2014;99(6): 1970–82. DOI:10.1210/jc.2014-1098; Frasoldati A., Valcavi R. Challenges in neck ultrasonography: lymphadenopathy and parathyroid glands. Endocr Pract 2004;10(3):261–8. DOI:10.4158/EP.10.3.261; Spencer C.A., Bergoglio L.M., Kazarosyan M. et al. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005;90(10):5566–75. DOI:10.1210/jc.2005-0671; https://ogsh.abvpress.ru/jour/article/view/810

Διαθεσιμότητα: https://ogsh.abvpress.ru/jour/article/view/810
https://doi.org/10.17650/2222-1468-2022-12-3-10-16

View record from BASE

5

Academic Journal

Central neck lymph node dissection for papillary thyroid cancer ; Центральная шейная лимфодиссекция при хирургическом лечении папиллярного рака щитовидной железы

Συγγραφείς: M. A. Kropotov, E. A. Grivachev, L. P. Yakovleva, A. V. Khodos, M. S. Tigrov, М. А. Кропотов, Е. А. Гривачев, Л. П. Яковлева, А. В. Ходос, М. С. Тигров

Πηγή: Malignant tumours; Том 9, № 2 (2019); 27-34 ; Злокачественные опухоли; Том 9, № 2 (2019); 27-34 ; 2587-6813 ; 2224-5057

Θεματικοί όροι: центральная клетчатка шеи, thyroidectomy, lymph node dissection, papillary cancer, well-differentiated thyroid cancer, hypoparathyroidism, recurrent laryngeal nerve, central adipose tissue of the neck, тиреоидэктомия, лимфодиссекция, папиллярный рак, высокодифференцированный рак щитовидной железы, гипопаратиреоз, возвратный нерв

Περιγραφή αρχείου: application/pdf

Relation: https://www.malignanttumors.org/jour/article/view/636/439; Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin (2011) 61 (2):61-90. doi:10.3322/caac.20; Hundahl SA, Fleming ID, Fremgen AM, Menck HR, et al. A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S. 1985-1995. Cancer (1998) 839 (12):2638-48. doi:10.1002/(SICI)1097-0142(19981215)83:123.0.CO;2-1; Kitamura Y, Shimizu K, Nagahama M, Sugino K, Ozaki O, Mimura T, et al. Immediate cuases of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab (1999) 84 (11):4043-94. doi:10.1210/jcem.84.11.6115; Grebe S.K., Hay I.D. Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg.Oncol.Clin.North Am., 1996, 5, 43-46.; Kouvaraki M.A., Shapiro S.E., Fornage B.D., et al. Role of preoperative ulthrasonography in the surgical management of patients with thyroid cancer. Surgery, 2003, 134, 946-954.; Л.П. Яковлева «Диагностика местнораспространенного рака щитовидной железы» Автореферат канд. Дисс. 2005.; Bhattacharyya N. Surgical treatment of cervical nodal metastases in patients with papillary thyroid carcinoma. Arch. Otolaryngol. Head Neck Surg. 2003, 129 (10), 1101-1104.; Scheumann G.F., Gimm O., Wegener G. et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J. Surg. 1994;18 (4):559-567.; Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med (1994) 97 (5):418-28. doi:10.1016/0002-9343(94)90321-2; Podnos YD, Smith D, Wagman LD, Ellenhorn JD. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg (2005) 71 (9):731-4.; Zaydfudim V, Feurer ID, Griffin MR, Phay JE. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery (2008) 144 (6):1070-7. doi:10.1016/j.surg.2008.08.034; Mazzaferri EL. A vision for the surgical management of papillary thyroid carcinoma: extensive lymph node compartmental dissections and selective use of radioiodine. J Clin Endocrinol Metab (2009) 94 (4):1086-8. doi:10.1210/jc.2009-0298; Zaydfudim V., Feurer I.D., Griffin M.R. et al. The impact of lymph node involvement on survival in patient with papillary and follicular thyroid carcinoma. Surgery, 2008, 144, 1070-1077.; Popadich A, Levin O, Lee JC, Smooke-Praw S, Ro K, Fazel M, et al. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery (2011) 150:1048-57. doi:10.1016/j.surg.2011.09.003; So YK, Seo MY, Son YI. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications. Surgery (2012) 151:192-8. doi:10.1016/j.surg.2011.02.004; Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery (2006) 140 (6):1000-5. doi:10.1016/j.surg.2006.08.001; Shan CX, Zhang W, Jiang DZ, Zheng XM, Liu S, Qiu M. Routine central neck dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis. Laryngoscope (2012) 122 (4):797-804. doi:10.1002/lary.22162; Roh JL, Kim JM, Park CL. Central compartment reoperation for recurrent / persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocalcemia. Ann Surg Oncol (2011) 18 (5):1312-8. doi:10.1245/s10434-010-1470-9.; Coatesworth AP, MacLennan K. Cervical metastasis in papillary carcinoma of the thyroid: a histopathological study. Int J Clin Pract (2002) 56:241-2.; Ducci M, Appetecchia M, Marzetti M. Neck dissection for surgical treatment of lymph node metastasis in papillary thyroid carcinoma. J Exp Clin Cancer Res (1997) 16:333-5.; Lee YS, Shin SC, Lim YS, Lee JC, Wang SG, Son SM, et al. Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer. Head Neck (2014) 36 (6):887-91. doi:10.1002/hed.23391; Chisholm EJ, Kulinskaya E, Tollery NS. Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone. Laryngoscope (2009) 119 (6):1135-9. doi:10.1002/lary.20236; Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer: revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2009) 19 (11):1167—214. doi:10.1089/thy.2009.0110; Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid (2016) 261:1-133. doi:10.1089/thy.2015.0020; Caronia LM, Phay JE, Shah MH. Role of BRAF in thyroid oncogenesis. Clin Cancer Res (2011) 17 (24):7511-7. doi:10.1158/1078-0432.CCR-11-1155; Kim SJ, Lee KE, Myong JP, Park JH, Jeon YK, Min HS, et al. BRAFV600E mutation is associated with tumor aggressiveness in papillary thyroid cancer. World J Surg (2012) 36:310-7. doi:10.1007/s00268-011-1383-1.; Tufano RP, Bishop J, Wu G. Reoperative central compartment dissection for patients with recurrent/ persistent papillary thyroid cancer: efficacy, safety, and association of the BRAF mutation. Laryngoscope (2012) 122:1634-40. doi:10.1002/lary.23371; Xing M, Tufano RP, Tufaro AP, Basaria S, Ewertz M, Rosenbaum E, et al. Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab (2004) 89 (6):2867-72. doi:10.1210/jc.2003-032050; Howell GM, Nikiforova MN, Carty SE, Armstrong MJ, Hodak SP, Stang MT, et al. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Ann Surg Oncol (2013) 20 (1):47-52.doi:10.1245/s10434-012-2611-0; Han PA, Kim HS, Cho S, Fazeli R, Najafian A, Khawaja H, et al. Association of BRAF V600E mutation and microRNA expression with central lymph node metastases in papillary thyroid cancer: a prospective study from four endocrine surgery centers. Thyroid (2016) 26 (4):532-42. doi:10.1089/thy.2015.0378; Kim SK, Woo JW, Lee JH, Park I, Choe JH, Kim JH, et al. Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma. Surgery (2015) 158 (6):1500—11. doi:10.1016/j.surg.2015.05.016; Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol (2014) 32 (25):2718-26. doi:10.1200/JC0.2014.55.5094; Ywata de Carvalho, A., Chulam, T.C., and Kowalski, L.P. Long-term results of observation vs prophylactic selective level VI neck dissection for papillary thyroid carcinoma at a cancer center. JAMA Otolaryngol Head Neck Surg. — 2015.-pp 141: 599-606; Ma, B., Wang, Y., Yang, S., and Ji, Q. Predictive factors for central lymph node metastasis in patients with cN0 papillary thyroid carcinoma: a systematic review and meta-analysis Int J Surg.2016.-pp 289: 153-161; https://www.malignanttumors.org/jour/article/view/636

Διαθεσιμότητα: https://www.malignanttumors.org/jour/article/view/636
https://doi.org/10.18027/2224-5057-2019-9-2-27-34

View record from BASE

6

Academic Journal

THE ROLE OF BRAF MUTATION STATUS IN SURGICAL TREATMENT OF WELL-DIFFERENTIATED THYROID CANCER ; ВЛИЯНИЕ СТАТУСА ГЕНА BRAF НА ВЫБОР ТАКТИКИ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ ВЫСОКОДИФФЕРЕНЦИРОВАННОГО РАКА ЩИТОВИДНОЙ ЖЕЛЕЗЫ

Συγγραφείς: A. P. Polyakov, N. N. Volchenko, E. N. Slavnova, A. V. Kudryavtseva, M. V. Ratushnyy, V. V. Ratushnaya, M. M. Filyushin, I. V. Rebrikova, P. A. Nikiforovich, А. П. Поляков, Н. Н. Волченко, Е. Н. Славнова, А. В. Кудрявцева, М. В. Ратушный, В. В. Ратушная, М. М. Филюшин, И. В. Ребрикова, П. А. Никифорович

Πηγή: Head and Neck Tumors (HNT); Том 6, № 4 (2016); 45-48 ; Опухоли головы и шеи; Том 6, № 4 (2016); 45-48 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2016-6-4

Θεματικοί όροι: метастазирование, well-differentiated thyroid cancer, BRAF gene, mutations, metastasis, высокодифференцированный рак щитовидной железы, ген BRAF, мутации

Περιγραφή αρχείου: application/pdf

Relation: https://ogsh.abvpress.ru/jour/article/view/250/245; Hodgson N.C., Button J., Solorzano C. et al. Thyroid cancer: is the incidence still increasing? Ann Surg Oncol 2004;11:1093–7.; Davies L., Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 2006;295(18):2164–7.; Davies H., Bignell G.R., Cox C. et al. Mutations of the BRAF gene in human cancer. Nature 2002;417(6892):949–54.; Xing М. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 2007;28(7):742–62.; Fugazzola L., Puxeddu E., Avenia N. et al. Correlation between В-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr Relat Cancer 2006;13(2): 455–64.; Basolo F., Torregrossa L., Giannini R. et al. Сorrelation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases. J Clin Endocrinol Metab 2010;95(9):4197–4205. DOI:10.1210/jc.2010-0337.; Xing M., Westra W.H., Tufano R.P. et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 2005;90(12): 6373–9.; Barollo S., Pennelli G., Vianello F. et al. BRAF in primary and recurrent papillary thyroid cancers: the relationship with (131)I and 2-[(18)F]fluoro-2-deoxy-D-glucose uptake ability. Eur J Endocrinol 2010;163(4):659–63.; Brose M.S., Schlumberger M., Peña C., Kappeler C. Sorafenib in radioactive iodinerefractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3. Lancet 2014;384(9940):319–28. DOI:10.1016/S0140-6736(14)60421-9.; https://ogsh.abvpress.ru/jour/article/view/250

Διαθεσιμότητα: https://ogsh.abvpress.ru/jour/article/view/250
https://doi.org/10.17650/2222-1468-2016-6-4-45-48

View record from BASE

7

Academic Journal